Cite
APA Citation
Kimby, E., Östenstad, B., Brown, P., Hagberg, H., Erlanson, M., Holte, H., Linden, O., Johansson, A., Ahlgren, T., Wader, K., Wahlin, B. E., Delabie, J., Sundström, C., & , (n.d.). two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Leukemia & lymphoma, 56(9), 2598–2607. http://access.bl.uk/ark:/81055/vdc_100089569274.0x000035